Garenoxacin
| CAS No. | 194804-75-6 | Cat. No. | BCP01415 |
| Name | Garenoxacin | ||
| Synonyms | BMS284756; BMS 284756; BMS-284756; T-3811;T 3811;Aids080974;Aids-080974; | ||
| Formula | C23H20F2N2O4 | M. Wt | 426.41 |
| Description | Garenoxacin is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity against common respiratory pathogens, including resistant strains. It has favourable pharmacokinetic profiles for maximum plasma concentration (Cmax) and area under the plasma concentration-time curve (AUC), with good penetration into sputum and otorhinolaryngological tissues. In clinical studies, the efficacy of Garenoxacin ranged from 92% to 96% in patients with bacterial pneumonia, mycoplasma pneumonia, chlamydial pneumonia and acute bronchitis. Garenoxacin is very effective in treating patients with upper and lower respiratory tract infections. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Antibiotic | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.